'Transparency' For The CRO?

Academic Discusses Industry

January 17, 2008

By SuzR

ClinPage recently caught up with Miriam Shuchman, author of the New England Journal of Medicine’s recent analysis of the contract research organization (CRO) industry. Instead of rehashing the NEJM article from October, which still has the industry wincing, we asked…

We're Not Sweatshops

ACRO Responds to NEJM

January 02, 2008

By SuzR

The recent New England Journal of Medicine (NEJM) article that criticized contract research organizations (CROs) was a roundhouse kick to the gut of that industry. The Oct. 4, 2007 article, written by New York psychiatrist and professor Miriam Shuchman, asserted…

Three Ticking Clocks

Bayer Halts Trasylol Sales

November 07, 2007

By Mark Uehling

In another significant win for medical journal editors in their new role as regulators, Bayer suspended sales of anti-clotting drug Trasylol (aprotinin), which had been implicated in kidney failure, cardiovascular problems and mortality risk. The drug had approximately $135 million…

CRO Industry In FDA Limbo?

NEJM Indicts CROs

October 18, 2007

By Mark Uehling

The October 4, 2007, edition of the New England Journal of Medicine (NEJM) is not online for free; we can’t link to it. But it contains a discussion of the booming contract research organization (CRO) industry. The CRO industry’s growth…

Clinipace, ICMJE, Axxora, ClinPhone

Today’s News

June 08, 2007

By info@clinpage.com

inVentiv Health selected ClinPhone EDC for its trials. Under the arrangement, inVentiv will transfer the technology in-house. Mike Hlinak, president and CEO of inVentiv Clinical Solutions said: “This agreement with ClinPhone allows us to further broaden our service offering by…